EPIC: At the forefront of biomedical research on eukaryotic pathogens
EPIC: At the forefront of biomedical research on eukaryotic pathogens
Clemson University’s Eukaryotic Pathogens Innovation Center — EPIC — is an interdisciplinary research cooperative founded in 2013 that is at the forefront of biomedical research on these devastating pathogens.
EPIC scientists have a lengthy track record of major contributions in this globally important area of research.
Congratulations to Dr. Jim Morris on his recent grant!
Dr. Jim Morris received a two year NIH award of $419k, which will support the development of genetic tools to study the brain-eating amoebae.
Project Number: NIH R21AI175463
Congratulations to Dr. Kozubowski on his two recent grants!
Dr. Lukasz Kozubowski (co-PI) in collaboration with Dr. Julia Brumaghim from the Department of Chemistry (PI) received an NSF award of $492k split between their two laboratories to study the mechanisms that lead to the development of resistance to azole drugs in Cryptococcus neoformans.
Project Name: Azole Antifungals Coordinate Metals and Create Reactive Oxygen Species That Damage DNA and Cause Chromosomal Instability
PAward Number (FAIN): 2203847
https://nsf.gov/awardsearch/showAward?AWD_ID=2203847&HistoricalAwards=false
The National Institute Of Allergy And Infectious Diseases awarded Dr. Lukasz Kozubowski a five-year grant of ~$1.9 total amount for 5 years to focus on a fungal infection associated with HIV/AIDS. The study will help to identify safer and more effective drugs that target cryptococcal infections like the life-threatening meningo-encephalitis in an immunocompromised host.
Project Name: The role of septins in the adaptation of Cryptococcus neoformans to host temperature in HIV-based cryptococcosis
Project Number: 1R01AI167692-01A1
https://reporter.nih.gov/search/CJzvGnP_kESu4MZKOQ4Zmw/project-details/10619216
Questions?
For further information about the EPIC please contact us.